Evidence map›Paper›PMID 31099936›Full record

ArticleAngewandte Chemie (International ed. in English)2019

Biocatalytic Strategy for Highly Diastereo- and Enantioselective Synthesis of 2,3-Dihydrobenzofuran-Based Tricyclic Scaffolds.

David A Vargas, Rahul L Khade, Yong Zhang, Rudi Fasan

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Engineered Myoglobin Catalysts for Asymmetric Intermolecular Cyclopropanation Reactions.Bulletin of Japan Society of Coordination Chemistry · 2022
    Article
  16. Engineered and Artificial Metalloenzymes for Selective C-H Functionalization.Current opinion in green and sustainable chemistry · 2021
    Article
  17. Article
  18. Review
  19. Biocatalytic Strategy for the Highly Stereoselective Synthesis of CHFAngewandte Chemie (International ed. in English) · 2021
    Article
  20. Insight into the preferential N-bindingDalton transactions (Cambridge, England : 2003) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

David A VargasDepartment of Chemistry, University of Rochester, 120 Trustee Road, Rochester, NY, 14627, USA.ORCID 0000-0002-6997-911X
Rahul L KhadeDepartment of Chemistry and Chemical Biology, Stevens Institute of Technology, Hoboken, NJ, 07030, USA.ORCID 0000-0003-3212-7949
Yong ZhangDepartment of Chemistry and Chemical Biology, Stevens Institute of Technology, Hoboken, NJ, 07030, USA.ORCID 0000-0001-7207-6416
Rudi FasanDepartment of Chemistry, University of Rochester, 120 Trustee Road, Rochester, NY, 14627, USA.ORCID 0000-0003-4636-9578

Funding

Selective P450 Oxidation Catalysts for Synthesis of Bioactive MoleculesR01GM098628 · NIGMS · UNIVERSITY OF TEXAS DALLAS · PI FASAN, RUDI · 2012 to 2024
$4.7M
National Science Foundation CHE-0946653National Science Foundation CHE-1300912National Science Foundation CHE-1725028NIGMS NIH HHS R01 GM098628NIH HHS GM098628
6 · The paper itself

Abstract

2,3-Dihydrobenzofurans are key pharmacophores in many natural and synthetic bioactive molecules. A biocatalytic strategy is reported here for the highly diastereo- and enantioselective construction of stereochemically rich 2,3-dihydrobenzofurans in high enantiopurity (>99.9% de and ee), high yields, and on a preparative scale via benzofuran cyclopropanation with engineered myoglobins. Computational and structure-reactivity studies provide insights into the mechanism of this reaction, enabling the elaboration of a stereochemical model that can rationalize the high stereoselectivity of the biocatalyst. This information was leveraged to implement a highly stereoselective route to a drug molecule and a tricyclic scaffold featuring five stereogenic centers via a single-enzyme transformation. This work expands the biocatalytic toolbox for asymmetric C-C bond transformations and should prove useful for further development of metalloprotein catalysts for abiotic carbene transfer reactions.

Indexed as

BenzofuransBiocatalysisModels, MolecularMolecular StructureMyoglobinProtein ConformationThermodynamicsBenzofuranscoumaranMyoglobinbenzofuran cyclopropanationbiocatalysiscarbene transferdihydrobenzofuransmyoglobin

Identifiers

PMID31099936
PMCPMC6640091

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.